158 related articles for article (PubMed ID: 32506754)
1. Epidemiological investigation for grouped cases of Trichosporon asahii using whole genome and IGS1 sequencing.
Desnos-Ollivier M; Maufrais C; Pihet M; Aznar C; Dromer F;
Mycoses; 2020 Sep; 63(9):942-951. PubMed ID: 32506754
[TBL] [Abstract][Full Text] [Related]
2. Invasive Infections Due to
Guo LN; Yu SY; Hsueh PR; Al-Hatmi AMS; Meis JF; Hagen F; Xiao M; Wang H; Barresi C; Zhou ML; de Hoog GS; Xu YC
J Clin Microbiol; 2019 Feb; 57(2):. PubMed ID: 30463892
[TBL] [Abstract][Full Text] [Related]
3. Molecular and antifungal susceptibility study on trichosporonemia and emergence of Trichosporon mycotoxinivorans as a bloodstream pathogen.
Dabas Y; Xess I; Kale P
Med Mycol; 2017 Jul; 55(5):518-527. PubMed ID: 27816903
[TBL] [Abstract][Full Text] [Related]
4. Molecular identification, genotyping, and antifungal susceptibility testing of clinically relevant Trichosporon species from Argentina.
Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G; Bosco-Borgeat ME
Med Mycol; 2014 May; 52(4):356-66. PubMed ID: 24682113
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing.
Chagas-Neto TC; Chaves GM; Melo AS; Colombo AL
J Clin Microbiol; 2009 Apr; 47(4):1074-81. PubMed ID: 19225102
[TBL] [Abstract][Full Text] [Related]
6. Genotyping, extracellular compounds, and antifungal susceptibility testing of Trichosporon asahii isolated from Mexican patients.
Montoya AM; Sánchez González A; Palma-Nicolás JP; Gómez-Treviño A; González JG; González GM
Med Mycol; 2015 Jun; 53(5):505-11. PubMed ID: 25980003
[TBL] [Abstract][Full Text] [Related]
7. Molecular Identification, Genotyping, Phenotyping, and Antifungal Susceptibilities of Medically Important Trichosporon, Apiotrichum, and Cutaneotrichosporon Species.
do Espírito Santo EPT; Monteiro RC; da Costa ARF; Marques-da-Silva SH
Mycopathologia; 2020 Apr; 185(2):307-317. PubMed ID: 31776790
[TBL] [Abstract][Full Text] [Related]
8. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
9. Three-locus identification, genotyping, and antifungal susceptibilities of medically important Trichosporon species from China.
Guo LN; Xiao M; Kong F; Chen SC; Wang H; Sorrell TC; Jiang W; Dou HT; Li RY; Xu YC
J Clin Microbiol; 2011 Nov; 49(11):3805-11. PubMed ID: 21900517
[TBL] [Abstract][Full Text] [Related]
10. Genotype analysis based on intergenic spacer 1 sequences of Trichosporon asahii collected in Taiwan.
Yang YL; Liu YW; Chen HT; Tsai MS; Chu WL; Lo HJ
Med Mycol; 2013 Nov; 51(8):880-3. PubMed ID: 23768241
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of VITEK 2 for discriminating Trichosporon species: misidentification of Trichosporon non-T. asahii.
de Figueiredo DS; de Almeida JN; Motta AL; Castro e Silva DM; Szeszs MW; Del Negro GM
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):59-61. PubMed ID: 24958642
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterisation and antifungal susceptibility of clinical Trichosporon isolates in India.
Rastogi V; Honnavar P; Rudramurthy SM; Pamidi U; Ghosh A; Chakrabarti A
Mycoses; 2016 Aug; 59(8):528-34. PubMed ID: 27144725
[TBL] [Abstract][Full Text] [Related]
13. Correlation of
Francisco EC; de Almeida Junior JN; Queiroz-Telles F; Aquino VR; Mendes AVA; de Oliveira Silva M; Castro PTOE; Guimarães T; Ponzio V; Hahn RC; Chaves GM; Colombo AL
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318016
[No Abstract] [Full Text] [Related]
14. Genetic analysis of emerging fungal pathogens: Trichosporon asahii.
Pumeesat P; Wongsuk T
Diagn Microbiol Infect Dis; 2023 Nov; 107(3):116057. PubMed ID: 37659120
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
[TBL] [Abstract][Full Text] [Related]
16. Sequence-based identification, genotyping and virulence factors of Trichosporon asahii strains isolated from urine samples of hospitalized patients (2011-2016).
Hazirolan G; Koçak N; Karagöz A
J Mycol Med; 2018 Sep; 28(3):452-456. PubMed ID: 29983233
[TBL] [Abstract][Full Text] [Related]
17. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients.
Xia Z; Yang R; Wang W; Cong L
Mycopathologia; 2012 Mar; 173(2-3):127-33. PubMed ID: 21979867
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and Antifungal Susceptibility of Infections Caused by
Singh S; Capoor MR; Varshney S; Gupta DK; Verma PK; Ramesh V
Indian J Med Microbiol; 2019; 37(4):536-541. PubMed ID: 32436877
[TBL] [Abstract][Full Text] [Related]
19. Sequence-based identification, genotyping and EUCAST antifungal susceptibilities of Trichosporon clinical isolates from Greece.
Arabatzis M; Abel P; Kanellopoulou M; Adamou D; Alexandrou-Athanasoulis H; Stathi A; Platsouka E; Milioni A; Pangalis A; Velegraki A
Clin Microbiol Infect; 2014 Aug; 20(8):777-83. PubMed ID: 24330082
[TBL] [Abstract][Full Text] [Related]
20. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients.
Mekha N; Sugita T; Ikeda R; Nishikawa A; Autthateinchai R; Poonwan N; Sawanpanyalert P
Mycopathologia; 2010 Jan; 169(1):67-70. PubMed ID: 19609716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
